Insight Molecular Diagnostics (IMDX) Receivables - Other (2017)

Insight Molecular Diagnostics (IMDX) posted Receivables - Other of $55000.0 for Q3 2017, up 66.67% sequentially from $33000.0 in Q2 2017.

Insight Molecular Diagnostics (IMDX) Receivables - Other (2017) Analysis & Trends

Insight Molecular Diagnostics (IMDX) has 1 years of Receivables - Other data on file, last reported at $55000.0 in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Insight Molecular Diagnostics	196.41 Mn	167.48 Mn	15,000.00

Download Data